- Home
- KEP vs ICLR Comparison
KEP vs ICLR Comparison
Compare KEP & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KEP
- ICLR
- Stock Information
- Founded
- KEP 1961
- ICLR 1990
- Country
- KEP South Korea
- ICLR Ireland
- Employees
- KEP N/A
- ICLR N/A
- Industry
- KEP Electric Utilities: Central
- ICLR Biotechnology: Commercial Physical & Biological Resarch
- Sector
- KEP Utilities
- ICLR Health Care
- Exchange
- KEP Nasdaq
- ICLR Nasdaq
- Market Cap
- KEP 13.3B
- ICLR 11.6B
- IPO Year
- KEP N/A
- ICLR 1998
- Fundamental
- Price
- KEP $13.05
- ICLR $143.54
- Analyst Decision
- KEP
- ICLR Buy
- Analyst Count
- KEP 0
- ICLR 12
- Target Price
- KEP N/A
- ICLR $187.82
- AVG Volume (30 Days)
- KEP 913.5K
- ICLR 1.2M
- Earning Date
- KEP 09-08-2025
- ICLR 07-23-2025
- Dividend Yield
- KEP 0.37%
- ICLR N/A
- EPS Growth
- KEP 667.18
- ICLR 11.53
- EPS
- KEP 5.56
- ICLR 9.19
- Revenue
- KEP $64,053,841,898.00
- ICLR $8,192,621,999.00
- Revenue This Year
- KEP $5.65
- ICLR N/A
- Revenue Next Year
- KEP $2.21
- ICLR $1.69
- P/E Ratio
- KEP $4.69
- ICLR $15.98
- Revenue Growth
- KEP 4.91
- ICLR N/A
- 52 Week Low
- KEP $6.68
- ICLR $125.10
- 52 Week High
- KEP $14.79
- ICLR $342.55
- Technical
- Relative Strength Index (RSI)
- KEP 53.14
- ICLR 45.87
- Support Level
- KEP $13.15
- ICLR $142.16
- Resistance Level
- KEP $13.95
- ICLR $153.62
- Average True Range (ATR)
- KEP 0.30
- ICLR 5.51
- MACD
- KEP -0.15
- ICLR -0.91
- Stochastic Oscillator
- KEP 2.40
- ICLR 10.04
About KEP Korea Electric Power Corporation
Korea Electric Power Corp is an electric utility company in which the government of South Korea holds a controlling stake. The firm operates in the following segments: Transmission and distribution, Electric power generation (Nuclear), Electric power generation (Non-Nuclear), Plant maintenance & engineering service, and Others. The majority of the energy produced by the company comes from its nuclear and coal-fired assets. Korea Electric Power generates revenue through the Transmission and distribution segment. Geographically, it derives maximum revenue from Domestic operations.
About ICLR ICON plc
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.